Literature DB >> 11577084

The Stat1 binding motif of the interferon-gamma receptor is sufficient to mediate Stat5 activation and its repression by SOCS3.

I Woldman1, L Varinou, K Ramsauer, B Rapp, T Decker.   

Abstract

Signal transduction via the interferon-gamma (IFN-gamma) receptor requires the tyrosine phosphorylation of signal transducers and activators of transcription (Stats). Whereas tyrosine phosphorylation of Stat1 occurs in all cells, activation of Stat5 by IFN-gamma is cell type-restricted. Here we investigated the mechanism of Stat5 activation by the IFN-gamma receptor. In transfection assays both Stat5 isoforms, Stat5a and Stat5b, were phosphorylated on tyrosine in response to IFN-gamma. Stat5 activation required the presence of tyrosine 420 (Tyr-420) in the murine IFNGR1 receptor chain, which also serves as the Stat1 binding site. Moreover, a peptide including Tyr-440, the Stat1 binding site of the human IFNGR1 chain, conferred the ability upon a synthetic receptor to activate Stat5. Suppressor of cytokine signaling 3 (SOCS3) inhibited the activation of Stat5 by the IFN-gamma receptor, and the Tyr-440-containing peptide stretch was sufficient for repression. SOCS3 expression had little effect on the activity of Jak kinases not associated with cytokine receptors. In IFN-gamma-treated, Stat1-deficient fibroblasts Stat5 was inefficient in inducing transcription of a Stat-dependent reporter gene, suggesting it does not per se make a major contribution to the expression of IFN-gamma-responsive genes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11577084     DOI: 10.1074/jbc.M105320200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  The molecular details of cytokine signaling via the JAK/STAT pathway.

Authors:  Rhiannon Morris; Nadia J Kershaw; Jeffrey J Babon
Journal:  Protein Sci       Date:  2018-12       Impact factor: 6.725

2.  JAK2 tyrosine kinase phosphorylates and is negatively regulated by centrosomal protein Ninein.

Authors:  Jennifer Jay; Alan Hammer; Andrea Nestor-Kalinoski; Maria Diakonova
Journal:  Mol Cell Biol       Date:  2014-10-20       Impact factor: 4.272

3.  Noncytolytic clearance of sindbis virus infection from neurons by gamma interferon is dependent on Jak/STAT signaling.

Authors:  Rebeca Burdeinick-Kerr; Dhanasekaran Govindarajan; Diane E Griffin
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

Review 4.  SOCS regulation of the JAK/STAT signalling pathway.

Authors:  Ben A Croker; Hiu Kiu; Sandra E Nicholson
Journal:  Semin Cell Dev Biol       Date:  2008-07-30       Impact factor: 7.727

5.  Regulation of multiple cytokine signalling pathways by SOCS3 is independent of SOCS2.

Authors:  Hiu Kiu; Christopher J Greenhalgh; Anne Thaus; Douglas J Hilton; Nicos A Nicola; Warren S Alexander; Andrew W Roberts
Journal:  Growth Factors       Date:  2009-12       Impact factor: 2.511

6.  Mutational switch of an IL-6 response to an interferon-gamma-like response.

Authors:  Ana P Costa-Pereira; Silvia Tininini; Birgit Strobl; Tonino Alonzi; Joerg F Schlaak; Hayaatun Is'harc; Ida Gesualdo; Sally J Newman; Ian M Kerr; Valeria Poli
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

7.  Host cell signalling and leishmania mechanisms of evasion.

Authors:  Marina Tiemi Shio; Kasra Hassani; Amandine Isnard; Benjamin Ralph; Irazu Contreras; Maria Adelaida Gomez; Issa Abu-Dayyeh; Martin Olivier
Journal:  J Trop Med       Date:  2011-11-03

8.  Bridging Radiotherapy to Immunotherapy: The IFN-JAK-STAT Axis.

Authors:  Lewis Zhichang Shi; James A Bonner
Journal:  Int J Mol Sci       Date:  2021-11-14       Impact factor: 5.923

Review 9.  JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies.

Authors:  Charlotte Ej Downes; Barbara J McClure; Daniel P McDougal; Susan L Heatley; John B Bruning; Daniel Thomas; David T Yeung; Deborah L White
Journal:  Front Cell Dev Biol       Date:  2022-07-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.